- Home
- WFG vs TLX Comparison
WFG vs TLX Comparison
Compare WFG & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFG
- TLX
- Stock Information
- Founded
- WFG 1955
- TLX 2015
- Country
- WFG Canada
- TLX Australia
- Employees
- WFG N/A
- TLX N/A
- Industry
- WFG
- TLX Biotechnology: Pharmaceutical Preparations
- Sector
- WFG
- TLX Health Care
- Exchange
- WFG Nasdaq
- TLX Nasdaq
- Market Cap
- WFG 7.5B
- TLX 6.0B
- IPO Year
- WFG N/A
- TLX N/A
- Fundamental
- Price
- WFG $76.89
- TLX $16.76
- Analyst Decision
- WFG Buy
- TLX Strong Buy
- Analyst Count
- WFG 3
- TLX 1
- Target Price
- WFG $105.00
- TLX $22.00
- AVG Volume (30 Days)
- WFG 192.9K
- TLX 31.6K
- Earning Date
- WFG 04-22-2025
- TLX 01-01-0001
- Dividend Yield
- WFG 1.66%
- TLX N/A
- EPS Growth
- WFG N/A
- TLX 798.14
- EPS
- WFG N/A
- TLX 0.09
- Revenue
- WFG $6,174,000,000.00
- TLX $484,687,790.00
- Revenue This Year
- WFG $5.31
- TLX N/A
- Revenue Next Year
- WFG $6.98
- TLX N/A
- P/E Ratio
- WFG N/A
- TLX $187.85
- Revenue Growth
- WFG N/A
- TLX 55.85
- 52 Week Low
- WFG $73.91
- TLX $14.01
- 52 Week High
- WFG $102.40
- TLX $30.36
- Technical
- Relative Strength Index (RSI)
- WFG 44.64
- TLX N/A
- Support Level
- WFG $75.20
- TLX N/A
- Resistance Level
- WFG $78.81
- TLX N/A
- Average True Range (ATR)
- WFG 1.63
- TLX 0.00
- MACD
- WFG 0.26
- TLX 0.00
- Stochastic Oscillator
- WFG 53.75
- TLX 0.00
About WFG West Fraser Timber Co. Ltd Common stock
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is now one of the largest oriented strand board, or OSB, producers in the world.
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.